Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

260

LikeLikedUnlike

16-30 of 365

Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiers
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
- Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
NeuroFrontiers
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
FA hiPSCs in Translational Drug Development
NeuroFrontiers
FA hiPSCs in Translational Drug Development
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiers
Proactive Pregnancy Planning and Reproductive Care in MS
- Riley Bove, MD, MMSc
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
NeuroFrontiers
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
- Aaron Miller, MD
Depression as a Signal of MS Progression
NeuroFrontiers
Depression as a Signal of MS Progression
advertisement
Updates in MS Care: Key Topics at AAN 2026
NeuroFrontiers
Updates in MS Care: Key Topics at AAN 2026
- Aaron Miller, MD
Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiers
Advancing Pediatric MS Care: Insights from AAN 2026
- Elizabeth Wilson, MD
Emerging Serum microRNAs as Early Signals in MS
NeuroFrontiers
Emerging Serum microRNAs as Early Signals in MS
Family Planning in Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning in Patients with Multiple Sclerosis
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiers
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
NeuroFrontiers
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
advertisement
The Burden of Cognitive Dysfunction in Multiple Sclerosis
NeuroFrontiers
The Burden of Cognitive Dysfunction in Multiple Sclerosis
- Christopher Lock, MD
Strategies to Safeguard Brain Health in MS
NeuroFrontiers
Strategies to Safeguard Brain Health in MS
- Christopher Lock, MD
Rethinking Progression in Multiple Sclerosis
NeuroFrontiers
Rethinking Progression in Multiple Sclerosis
- Charles Turck, PharmD, BCPS, BCCCP
- Christopher Lock, MD

Program Chapters

Segment Chapters

Playlist:

Recommended